Analyst Insights
Nektar Therapeutics (NKTR) is ready for next Episode as it posted an annual sales of 90,120 K
Nektar Therapeutics (NASDAQ: NKTR) on Tuesday, soared 3.60% from the previous trading day, before settling in for the closing price of $1.39. Within the past
